At this regard, PLCE1 is likely a unique substrate of TAK1 for transducing its inhibitory effects on ESCC migration and invasion, although some other signaling pathways are also affected by TAK1. The gene discussed is MAP3K7; the disease is esophageal squamous cell carcinoma.